No Data
No Data
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences Agrees to Pay $202 Million to Settle Claims of Kickbacks to Doctors for HIV Drug Prescriptions
Express News | U.S. Attorney in Manhattan Announces $202 Mln Settlement With Gilead Sciences for Using Speaker Programs to Pay Kickbacks to Doctors
CIBC Introducing Additional U.S. Canadian Depositary Receipts
Gilead To Present New Research To EASL Congress
Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV's Impact in the United States
小粉红的papa : It seems that not many people pay attention to biopharmaceutical Stocks, it's quite niche.
Everyone only invests in Technology Stocks.